Deirdre K Tobias1, An Pan, Chandra L Jackson, Eilis J O'Reilly, Eric L Ding, Walter C Willett, JoAnn E Manson, Frank B Hu. 1. From the Departments of Nutrition (D.K.T., A.P., C.L.J., E.J.O., E.L.D., W.C.W., F.B.H.) and Epidemiology (W.C.W., J.E.M., F.B.H.), Harvard School of Public Health, and the Channing Division of Network Medicine (E.J.O., E.L.D., W.C.W., F.B.H.) and the Division of Preventive Medicine (J.E.M.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School - all in Boston; and Saw Swee Hock School of Public Health and Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore (A.P.).
Abstract
BACKGROUND: The relation between body weight and mortality among persons with type 2 diabetes remains unresolved, with some studies suggesting decreased mortality among overweight or obese persons as compared with normal-weight persons (an "obesity paradox"). METHODS: We studied participants with incident diabetes from the Nurses' Health Study (8970 participants) and Health Professionals Follow-up Study (2457 participants) who were free of cardiovascular disease and cancer at the time of a diagnosis of diabetes. Body weight shortly before diagnosis and height were used to calculate the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters). Multivariable Cox models were used to estimate the hazard ratios and 95% confidence intervals for mortality across BMI categories. RESULTS: There were 3083 deaths during a mean period of 15.8 years of follow-up. A J-shaped association was observed across BMI categories (18.5 to 22.4, 22.5 to 24.9 [reference], 25.0 to 27.4, 27.5 to 29.9, 30.0 to 34.9, and ≥35.0) for all-cause mortality (hazard ratio, 1.29 [95% confidence interval {CI}, 1.05 to 1.59]; 1.00; 1.12 [95% CI, 0.98 to 1.29]; 1.09 [95% CI, 0.94 to 1.26]; 1.24 [95% CI, 1.08 to 1.42]; and 1.33 [95% CI, 1.14 to 1.55], respectively). This relationship was linear among participants who had never smoked (hazard ratios across BMI categories: 1.12, 1.00, 1.16, 1.21, 1.36, and 1.56, respectively) but was nonlinear among participants who had ever smoked (hazard ratios across BMI categories: 1.32, 1.00, 1.09, 1.04, 1.14, and 1.21) (P=0.04 for interaction). A direct linear trend was observed among participants younger than 65 years of age at the time of a diabetes diagnosis but not among those 65 years of age or older at the time of diagnosis (P<0.001 for interaction). CONCLUSIONS: We observed a J-shaped association between BMI and mortality among all participants and among those who had ever smoked and a direct linear relationship among those who had never smoked. We found no evidence of lower mortality among patients with diabetes who were overweight or obese at diagnosis, as compared with their normal-weight counterparts, or of an obesity paradox. (Funded by the National Institutes of Health and the American Diabetes Association.).
BACKGROUND: The relation between body weight and mortality among persons with type 2 diabetes remains unresolved, with some studies suggesting decreased mortality among overweight or obesepersons as compared with normal-weight persons (an "obesity paradox"). METHODS: We studied participants with incident diabetes from the Nurses' Health Study (8970 participants) and Health Professionals Follow-up Study (2457 participants) who were free of cardiovascular disease and cancer at the time of a diagnosis of diabetes. Body weight shortly before diagnosis and height were used to calculate the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters). Multivariable Cox models were used to estimate the hazard ratios and 95% confidence intervals for mortality across BMI categories. RESULTS: There were 3083 deaths during a mean period of 15.8 years of follow-up. A J-shaped association was observed across BMI categories (18.5 to 22.4, 22.5 to 24.9 [reference], 25.0 to 27.4, 27.5 to 29.9, 30.0 to 34.9, and ≥35.0) for all-cause mortality (hazard ratio, 1.29 [95% confidence interval {CI}, 1.05 to 1.59]; 1.00; 1.12 [95% CI, 0.98 to 1.29]; 1.09 [95% CI, 0.94 to 1.26]; 1.24 [95% CI, 1.08 to 1.42]; and 1.33 [95% CI, 1.14 to 1.55], respectively). This relationship was linear among participants who had never smoked (hazard ratios across BMI categories: 1.12, 1.00, 1.16, 1.21, 1.36, and 1.56, respectively) but was nonlinear among participants who had ever smoked (hazard ratios across BMI categories: 1.32, 1.00, 1.09, 1.04, 1.14, and 1.21) (P=0.04 for interaction). A direct linear trend was observed among participants younger than 65 years of age at the time of a diabetes diagnosis but not among those 65 years of age or older at the time of diagnosis (P<0.001 for interaction). CONCLUSIONS: We observed a J-shaped association between BMI and mortality among all participants and among those who had ever smoked and a direct linear relationship among those who had never smoked. We found no evidence of lower mortality among patients with diabetes who were overweight or obese at diagnosis, as compared with their normal-weight counterparts, or of an obesity paradox. (Funded by the National Institutes of Health and the American Diabetes Association.).
Authors: Mercedes R Carnethon; Peter John D De Chavez; Mary L Biggs; Cora E Lewis; James S Pankow; Alain G Bertoni; Sherita H Golden; Kiang Liu; Kenneth J Mukamal; Brenda Campbell-Jenkins; Alan R Dyer Journal: JAMA Date: 2012-08-08 Impact factor: 56.272
Authors: Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun Journal: N Engl J Med Date: 2010-12-02 Impact factor: 91.245
Authors: Stephanie E Chiuve; Teresa T Fung; Eric B Rimm; Frank B Hu; Marjorie L McCullough; Molin Wang; Meir J Stampfer; Walter C Willett Journal: J Nutr Date: 2012-04-18 Impact factor: 4.798
Authors: Seth Uretsky; Franz H Messerli; Sripal Bangalore; Annette Champion; Rhonda M Cooper-Dehoff; Qian Zhou; Carl J Pepine Journal: Am J Med Date: 2007-10 Impact factor: 4.965
Authors: T Pischon; H Boeing; K Hoffmann; M Bergmann; M B Schulze; K Overvad; Y T van der Schouw; E Spencer; K G M Moons; A Tjønneland; J Halkjaer; M K Jensen; J Stegger; F Clavel-Chapelon; M-C Boutron-Ruault; V Chajes; J Linseisen; R Kaaks; A Trichopoulou; D Trichopoulos; C Bamia; S Sieri; D Palli; R Tumino; P Vineis; S Panico; P H M Peeters; A M May; H B Bueno-de-Mesquita; F J B van Duijnhoven; G Hallmans; L Weinehall; J Manjer; B Hedblad; E Lund; A Agudo; L Arriola; A Barricarte; C Navarro; C Martinez; J R Quirós; T Key; S Bingham; K T Khaw; P Boffetta; M Jenab; P Ferrari; E Riboli Journal: N Engl J Med Date: 2008-11-13 Impact factor: 91.245
Authors: Laura N McEwen; Andrew J Karter; Beth E Waitzfelder; Jesse C Crosson; David G Marrero; Carol M Mangione; William H Herman Journal: Diabetes Care Date: 2012-03-19 Impact factor: 19.112
Authors: John R B Perry; Benjamin F Voight; Loïc Yengo; Najaf Amin; Josée Dupuis; Martha Ganser; Harald Grallert; Pau Navarro; Man Li; Lu Qi; Valgerdur Steinthorsdottir; Robert A Scott; Peter Almgren; Dan E Arking; Yurii Aulchenko; Beverley Balkau; Rafn Benediktsson; Richard N Bergman; Eric Boerwinkle; Lori Bonnycastle; Noël P Burtt; Harry Campbell; Guillaume Charpentier; Francis S Collins; Christian Gieger; Todd Green; Samy Hadjadj; Andrew T Hattersley; Christian Herder; Albert Hofman; Andrew D Johnson; Anna Kottgen; Peter Kraft; Yann Labrune; Claudia Langenberg; Alisa K Manning; Karen L Mohlke; Andrew P Morris; Ben Oostra; James Pankow; Ann-Kristin Petersen; Peter P Pramstaller; Inga Prokopenko; Wolfgang Rathmann; William Rayner; Michael Roden; Igor Rudan; Denis Rybin; Laura J Scott; Gunnar Sigurdsson; Rob Sladek; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Jaakko Tuomilehto; Andre G Uitterlinden; Sidonie Vivequin; Michael N Weedon; Alan F Wright; Frank B Hu; Thomas Illig; Linda Kao; James B Meigs; James F Wilson; Kari Stefansson; Cornelia van Duijn; David Altschuler; Andrew D Morris; Michael Boehnke; Mark I McCarthy; Philippe Froguel; Colin N A Palmer; Nicholas J Wareham; Leif Groop; Timothy M Frayling; Stéphane Cauchi Journal: PLoS Genet Date: 2012-05-31 Impact factor: 5.917
Authors: Vasanti S Malik; Yanping Li; An Pan; Lawrence De Koning; Eva Schernhammer; Walter C Willett; Frank B Hu Journal: Circulation Date: 2019-04-30 Impact factor: 29.690
Authors: Adela Hruby; JoAnn E Manson; Lu Qi; Vasanti S Malik; Eric B Rimm; Qi Sun; Walter C Willett; Frank B Hu Journal: Am J Public Health Date: 2016-07-26 Impact factor: 9.308